Pulmonary drug delivery Market Research” Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

Pulmonary drug delivery is a developed technique in which drugs are inhaled through the lungs and enter the bloodstream through the alveolar epithelium. Pulmonary drug delivery provides a non-invasive alternative method for subcutaneous and intravenous injection. Delivery devices play an important role in the efficiency of lung delivery, and in recent years, great progress has been made in the development of new devices. The most commonly used devices for respiratory delivery,including nebulizers , metered dose inhalers, and dry powder inhalers, can all be used with protein/peptide drugs.

Key players

• Glaxo Smith Kline plc
• Philips Respironics
• Boehringer Ingelheim GmbH
• Novartis AG
• 3M Healthcare
• GF Health Products, Inc.
• Merck & Co., Inc.
• AstraZeneca

Product

• Metered Dose Inhalers
• Dry Powder Inhalers
• Nebulizers
• Mesh
• Vibrating
• Static
• Pneumatic
• Vented
• Breath Actuated
• Ultrasonic
• Accessories

Application

• Asthma
• Cystic Fibrosis
• COPD
• Allergic Rhinitis
• Others

Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• E-Commerce

End-use

• Hospitals & Clinics
• Home care

Scope of the Report

The research study analyzes the global Expanded per lite industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
 Market Overview and growth analysis
 Import and Export Overview
 Volume Analysis
 Current Market Trends and Future Outlook
 Market Opportunistic and Attractive Investment Segment

A full report of Global   Pulmonary drug delivery Market Research” is available at: 

Geographic Coverage

 North America Market Size and/or Volume
 Latin America Market Size and/or Volume
 Europe Market Size and/or Volume